Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.

G MarcucciG BeccutiG CarosiF CetaniL CianferottiA M ColaoC Di SommaM DuradoniA ElefanteL GhizzoniM GiustiA G LaniaE LavezziB MadeoG MantovaniC MarcocciL MasiS ParriF PigliaruA SantonatiA SpadaL VeraMaria Luisa Brandi

Published in: Journal of endocrinological investigation (2022)

Biochemical and clinical results confirm the efficacy and safety of rhPTH (1-84) therapy, which represents an important option for hypoparathyroid patients unresponsive to conventional therapy.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
clinical trial
patient reported outcomes
mesenchymal stem cells
replacement therapy